002099.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:04):

Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally...

Stats
Dzisiejszy wolumen	10.36M
Średni wolumen	14.20M
Kapitalizacja rynkowa	10.06B
EPS	CNY0 ( 2023-10-30 )
Następna data zysków	( CNY0 ) 2024-05-20
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-24.38
ATR14	CNY0.0110 (0.17%)

Wolumen Korelacja

Długi: -0.02 (neutral)

Krótki: -0.84 (strong negative)

Signal:(53.065) Neutral

Zhejiang Hisoar Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhejiang Hisoar Korelacja - Waluta/Towar

0.38
( neutral )

0.19
( neutral )

0.00
( neutral )

0.35
( neutral )

-0.43
( neutral )

0.11
( neutral )

Zhejiang Hisoar Finanse

Annual	2023
Przychody:	CNY2.17B
Zysk brutto:	CNY304.64M (14.03 %)
EPS:	CNY-0.260

FY	2023
Przychody:	CNY2.17B
Zysk brutto:	CNY304.64M (14.03 %)
EPS:	CNY-0.260

FY	2022
Przychody:	CNY2.70B
Zysk brutto:	CNY720.27M (26.64 %)
EPS:	CNY0.0544

FY	2021
Przychody:	CNY2.48B
Zysk brutto:	CNY925.44M (37.24 %)
EPS:	CNY0.0600

Financial Reports:

No articles found.

Zhejiang Hisoar

Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.